Traphagen Investment Advisors LLC Bausch Health Companies Inc. Transaction History

Traphagen Investment Advisors LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Jun 17, 2024	SELL	$14.88 - $20.13 $245,520 - $332,145	-16,500 Closed	0 $0
Q2 2020 Jun 17, 2024	BUY	$13.31 - $20.51 $219,615 - $338,415	16,500 New	16,500 $302 Million
Q1 2020 Jun 17, 2024	BUY	$12.98 - $30.25 $213,196 - $496,856	16,425 New	16,425 $255 Million
Q4 2019 Jun 17, 2024	BUY	$18.89 - $31.89 $289,678 - $489,033	15,335 New	15,335 $459 Million
Q3 2019 Jun 17, 2024	BUY	$20.88 - $25.66 $341,910 - $420,182	16,375 New	16,375 $358 Million
Q2 2019 Jun 17, 2024	BUY	$20.52 - $26.45 $336,015 - $433,118	16,375 New	16,375 $413 Million
Q1 2019 Jun 17, 2024	BUY	$20.23 - $26.29 $331,266 - $430,498	16,375 New	16,375 $404 Million

254

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.7B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Traphagen Investment Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Traphagen Investment Advisors LLC with notifications on news.